Stakeholders suggested that while the FDA rule is dead, updates to LDT regulation are coming, nonetheless, and the industry ...

Developed as part of a broader collaboration between the two firms, the tool uses generative AI to let providers ask questions and describe conditions in plain language.

The development marks a shift up the value chain for labs and could prove a meaningful revenue stream for providers able to ...

China's volume-based procurement policy and US tariffs have forced companies with large businesses in China to reset their ...

Danaher subsidiaries Beckman Coulter, Cepheid, and Leica Biosystems will be working together with external partners to focus ...

Through clinical trials, partnerships, and economic studies, a crop of test developers is trying to prove the value of their ...

The laboratory medicine organization is focused on the benefits of using data science within laboratories to more effectively care for patients and track utilization.

Cemhan Biricik, CEO of Fast Lab Technologies, and Martin Perlin, its medical director, are alleged to have billed public and private payors for testing that was never done.

NEW YORK – After a brief respite from declining share prices in June, diagnostic firms lost that momentum in July as the 360Dx Top 30 fell 2 percent during the month. The Top 30 contrasted the broader ...

An assessment of the documentation for 30 over-the-counter diagnostic tests found none met the current regulatory standards.

NEW YORK – Though its business has been somewhat stymied the past few years by long-lasting supply chain struggles followed by an extended biopharma downturn coupled with headwinds challenging the ...